obesity drug news today glp-1 september 29 2025 Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Medicine Association, and The Obesity Society GLP-1 Agonists: Using Semaglutide, Tirzepatide,
Description
Yang, Y
Although not contraindicated, clinicians should closely monitor thyroid function tests and adjust therapy as weight and metabolic status evolve under GLP-1RA treatment [65]
Real-world studies have shown the safety and tolerability of GLP-1RAs in MS [41,62]
Interestingly, the degree of weight loss associated with GLP-1 RAs appears to be less noticeable in individuals with T2D
Available from: Hall KD, Kahan S
